Clinical Trial Update: New Formulation and Food Effect Study of BIIB074 [Phase 1]

View source ↗

Summary

Biogen conducted a Phase 1 study evaluating a new formulation of BIIB074 and the effect of food on its pharmacokinetics. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Trigeminal Neuralgia

Drugs mentioned

• BIIB074

Snippet

Sponsor: Biogen | Conditions: Trigeminal Neuralgia (TN), Other Neuropathic Pain | Phase 1 | Status: COMPLETED